Skip to main content

Breast Lipomodelling Outcome Following Conservative Breast Cancer Surgery and Reconstructive Surgery in a District Hospital | Chapter 13 | New Frontiers in Medicine and Medical Research Vol. 9

Lipomodelling has recently become more popular for correcting flaws and asymmetry after oncologic breast cancer treatment [1]. The current evidence on the efficacy of breast reconstruction using lipomodelling following breast cancer treatment is insufficient, and there are no substantial safety issues [2].

For both safety and efficacy, we verified our outcome results against the NICE guidelines. All lipomodelling cases performed in Northumbria Healthcare NHS Foundation Trust between 04/2011 and 04/2013 were analysed retrospectively.

The trial involved 36 patients, with an average volume of fat injected of 113.91mls each session. The Cytori approach had the lowest rate of problems at 11%, compared to 44% and 45% for Coleman and body jet techniques, respectively.

The number of sessions for each patient, the length of hospital stay, and the amount of fat collected and injected in each patient all fulfilled the NICE guidelines criteria.

We didn't meet the guidelines in the following areas: volume change; no definite tool was used other than clinical assessment; 80 percent of patients had very good and good aesthetic outcomes, compared to NICE's 87 percent; and aesthetic outcome was absent in 8% of patients, compared to NICE's 2.7 percent. In terms of safety, we met NICE standards in terms of local recurrence rates of 1%, local infection rates of 1%, pneumothorax, and fat embolism (0 percent ). However, we had a higher rate of liponecrosis (13 percent vs. 3%), as well as liponecrotic cysts (8.33 percent vs. 7%), using the Body jet approach.

Conclusion: Lipomodelling is a safe operation that can be performed at District general hospitals with comparable results after breast cancer surgery.


Author (S) Details

M. Metry
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

M. Shaaban
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

B. Edgar
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

M. Youssef
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

N. Mclean
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

M. Carr
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

P. Sierra
Breast Surgery Department Northumbria Healthcare NHS Trust, UK.

 


View Book :- https://stm.bookpi.org/NFMMR-V9/article/view/3464

Labels:

Comments

Post a Comment

Popular posts from this blog

Greening Regional Airports: A Vision for Carbon Neutral Infrastructure | Chapter 12 | Contemporary Perspective on Science, Technology and Research Vol. 3

 This study provides an overview of the energy demand of a regional airport, divided into individual time horizons. The electrification of aircraft systems raises the question of whether airports will be among the largest electricity consumers in our infrastructure in the future. Sustainability and especially emission reductions are significant challenges for airports that are currently being addressed. The Clean Sky 2 project GENESIS addresses the environmental sustainability of hybrid-electric 50-passenger aircraft systems in a life cycle perspective to support the development of a technology roadmap for the transition to sustainable and competitive electric aircraft systems. This article originates from the GENESIS research and describes various options for ground power supply at a regional airport. Potential solutions for airport infrastructure with a short (2030), medium (2040), and long (2050) time horizon are proposed. In addition to the environmental and conservation benefi...
Post a Comment
Read more

Alkali Element Modification of Glucose Molecules as a Method to Dissolve Cancer Cells | Chapter 12 | New Visions in Medicine and Medical Science Vol. 4

  The present study highlights about alkali element modification of glucose molecules as a method to dissolve cancer cells. The central regulation of the mechanisms governing cell proliferation has little effect on cancer cells. Cancer cells are entirely independent of the central command and divide and proliferate on their own, making it challenging to activate their response mechanism. Precisely, this is the reason why they are at risk to the health of humans and/or any biological entities. Instead of trying to reconnect the central command of the growth control mechanism to cancer cells that are already out of the range, we present a method of using the cancer cell’s own irresponsive and uncontrolled growth mechanism to their disadvantage and destroy the cancer cells. We found that this is achievable in an atomic/molecular level study of the glucose molecule, which is the primary food source used for growth and energy generation by all cells in the body, including the cancer cel...
Post a Comment
Read more

Diagnosis and Management of Scrapie in Post Mortem Goats by Immunohistochemistry | Chapter 6 | New Visions in Medicine and Medical Science Vol. 4

  The main objective of this study was to contribute to the annual passive surveillance for this pathology, since the goats are a species considered reservoir for the prion. A class of pathologies known as Transmissible Spongiform Illnesses (TSEs), which affect both humans and animals, includes scrapie, a neurological disease with a slow and deadly course that affects sheep, goats, and mouflons. Given that Immunohistochemistry (IHC) is the globally accepted technique for identifying classical scrapie in goats—a species thought to be a potential zoonotic disease reservoir. Chile in relation to Bovine Spongiform Encephalopathy (BSE), is classified as a disease-free country. Scrapie is actively monitored for the sheep, but passively for the caprine species, which is why this study was carried out in slaughtered goats in the central north of the country (IV Region), to provide information to the surveillance system for this disease. Fifty brains of goats older than 2 years were used, r...
Post a Comment
Read more